Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the ...

Detailed price information for SC Pharmaceuticals Inc (SCPH-Q) from The Globe and Mail including charting and trades.

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...

Detailed price information for SC Pharmaceuticals Inc (SCPH-Q) from The Globe and Mail including charting and trades.

Fintel reports that on August 25, 2025, Maxim Group downgraded their outlook for scPharmaceuticals (NasdaqGS:SCPH) from Buy ...

MannKind will acquire scPharmaceuticals in a $360 million deal, adding Furoscix and expanding into cardiometabolic care with ...

Investing.com -- MannKind Corporation (NASDAQ:MNKD) shares dropped 2% on Monday after the company announced it will acquire ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of scPharmaceuticals Inc. (NASDAQ: SCPH) to MannKind Corporation is fair to scPharmaceuticals shareholders. Under the ...

MannKind to acquire scPharmaceuticals for $303M, expanding into cardiorenal medicine with Furoscix. Read more here.

“Given the low sales price, we are investigating whether the SCPH Board of Directors acted in the best interests of SCPH shareholders in approving the sale,” explained Joshua Fruchter, a ...

On August 24, 2025, scPharmaceuticals entered into a merger agreement with MannKind Corporation, which will acquire all outstanding shares of scPharmaceuticals through a tender offer. The acquisition, ...

Acquisition expected to diversify and accelerate double-digit revenue growth with FUROSCIX®, an innovative treatment for ...